Virus-Related Carcinoma — Trials

Virus-Related Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

169 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 74
Recruiting: 38
Ph III recruiting: 2
Growth YoY: —
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (15)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06454175	A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years	unknown	Phase 1	72	Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY	1	Jan 6, 2025	clinicaltrials
NCT03475953	A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors(REGOMUNE)	unknown	Phase 1 / Phase 2	747	Institut BergoniéOTHER	1	Mar 3, 2023	clinicaltrials